Summary
-
1.
New information identifying nucleotide alterations of human butyrylcholinesterase allows the use of more specific nomenclature for the variants commonly known as atypical, fluoride, silent, and K variant.
-
2.
In addition to suggesting a system of trivial names and abbreviations, we provide a list of formal names that follow the guidelines of the Committee for Human Gene Nomenclature.
-
3.
It is suggested that formal names be included in publications whenever possible.
Similar content being viewed by others
References
Arpagaus, M., Kott, M., Vatsis, K. P., Bartels, C. F., La Du, B. N., and Lockridge, O. (1990). Structure of the gene for human butyrylcholinesterase. Evidence for a single copy.Biochemistry 29124–131.
Bartels, C. F., van der Spek, A., Lockridge, O., and La Du, B. N. (1989). A polymorphism (K variant?) of human serum cholinesterase at nucleotide 1615, coding for Ala/Thr 539.FASEB J. 3:A741.
Delbruck, A., and Henkel, E. (1979). A rare genetically determined variant of pseudocholinesterase in two German families with high plasma enzyme activity.Eur. J. Biochem. 9965–69.
Eckerson, H. W., Oseroff, A., Lockridge, O., and La Du, B. N. (1983). Immunological comparison of the usual and atypical human serum cholinesterase phenotypes.Biochem. Genet. 2193–108.
Eiberg, H., Nielsen, L. S., Klausen, J., Dahlen, M., Kristensen, M., Bisgaard, M. L., Moller, N., and Mohr, J. (1989). Linkage between serum cholinesterase 2 (CHE2) andγ-crystallin gene cluster (CRYG): Assignment to chromosome 2.Clin Genet. 35313–321.
Evans, R. T., and Wardell, J. (1984). On the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian population.J. Med. Genet. 2199–102.
Garry, P. J., Dietz, A. A., Lubrano, T., Ford, P. C., James, K., and Rubinstein, H. M. (1976). New allele at cholinesterase locus 1.J. Med Genet. 13 38–42.
Harris, H., and Whittaker, M. (1961). Differential inhibition of human serum cholinesterase with fluoride. Recognition of two new phenotypes.Nature Lond. 191496–498.
Harris, H., Robson, E. B., Glen-Bott, A. M., and Thornton, J. A. (1963). Evidence for non-allelism between genes affecting human serum cholinesterase.Nature 2001185–1187.
Kalow, W. (1962).Pharmacogenetics, Heredity and the Response to Drugs. W. B. Saunders, Philadelphia, pp. 69–93.
Kalow, W., and Genest, K. (1957). A method for the detection of atypical forms of human cholinesterase; Determination of dibucaine numbers.Can. J. Biochem. Physiol. 35339–346.
Kalow, W., and Gunn, D. R. (1959). Some statistical data on atypical cholinesterase of human serum.Ann. Hum. Genet. 23239–250.
Kalow, W., and Lindsay, H. A. (1955). A comparison of optical and manometric methods for the assay of human serum cholinesterase.Can. J. Biochem. Physiol. 33568–574.
Kalow, W., and Staron, N. (1957). On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers.Can. J. Biochem. Physiol. 351305–1320.
Krause, A., Lane, A. B., and Jenkins, T. (1988). A new high activity plasma cholinesterase variant.J. Med. Genet. 25677–681.
La Du, B. N., Bartels, C. F., Nogueira, C. P., Hajra, A., Lightstone, H., van der Spek, A., and Lockridge, O. (1990). Phenotypic and molecular biological analysis of human serum cholinesterase variants.Clin. Biochem. 23423–431.
Liddell, J., Lehmann, H., and Silk, E. (1962). A “silent” pseudocholinesterase gene.Nature (Lond.)193561–562.
Lockridge, O. (1990). Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine.Pharmacol. Ther. 4735–60.
Lockridge, O., and La Du, B. N. (1978). Comparison of atypical and usual human serum cholinesterase: Purification, number of active sites, substrate affinity, and turnover number.J. Biol. Chem. 253361–366.
Lovrien, E. W., Magenis, R. E., Rivas, M. L., Lamvik, N., Rowe, S., Wood, J., and Hemmerling, J. (1978). Serum cholinesterase (E2) linkage analysis: Possible evidence for localization to chromosome 16.Cytogenet. Cell Genet. 22324–325.
Marazita, M. L., Keats, B. J. B., Spence, M. A., Sparkes, R. S., Field, L. L., Sparkes, M. C., and Crist, M. (1989). Mapping studies of the serum cholinesterase-2 locus (CHE2).Hum. Genet. 83139–144.
Masson, P. (1989). A naturally-occurring molecular form of human plasma cholinesterase is an albumin conjugate.Biochim. Biophys. Acta 988258–266.
Masson, P., Chatonnet, A., and Lockridge, O. (1990). Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant (CHE2).FEBS Lett. 262115–118.
McGuire, M. C., Nogueira, C. P., Bartels, C. F., Lightstone, H., Hajra, A., van der Spek, A. F. L., Lockridge, O., and La Du, B. N. (1989). Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase.Proc. Natl. Acad. Sci. USA 86953–957.
Neitlich, H. W. (1966). Increased plasma cholinesterase activity and succinylcholine resistance: A genetic variant.J. Clin. Invest. 45380–387.
Nogueira, C. P., McGuire, M. C., Graeser, C., Bartels, C. F., Arpagaus, M., van der Spek, A. F. L., Lightstone, H., Lockridge, O., and La Du, B. N. (1990). Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117, (GGT→GGAG).Am. J. Hum. Genet. 46934–942.
Olson, M., Hood, L., Cantor, C., and Botstein, D. (1989). A common language for physical mapping of the human genome.Science 2451434–1435.
Robson, E. B., and Harris, H. (1966). Further data on the incidence and genetics of the serum cholinesterase phenotype C5+.Ann. Hum. Genet. Lond. 29403–408.
Robson, E. B., Sutherland, I., and Harris, H. (1966). Evidence for linkage between the transferrin locus (Tf) and the serum cholinesterase locus (El) in man.Ann. Hum. Genet. Lond. 29325–332.
Rubinstein, H. M., Dietz, A. A., Hodges, L. K., Lubrano, T., and Czebotar, V. (1970). Silent cholinesterase gene: Variations in the properties of serum enzyme in apparent homozygotes.J. Clin. Invest. 49479–486.
Rubinstein, H. M., Dietz, A. A., and Lubrano, T. (1978). E k1 , another quantitative variant at cholinesterase locus 1.J. Med. Genet. 1527–29.
Savarese, J. J., Ali, H. H., Basta, S. J., Embree, P. B., Scott, R. P. F., Sunder, N., Weakly, J. N., Wastila, W. B., and El-Sayad, H. A. (1988). The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.Anesthesiology 68723–732.
Scott, E. M., and Powers, R. F. (1974). Properties of the C5 variant form of human serum cholineserase.Am. J. Hum. Genet. 26189–194.
Shows, T. B., McAlpine, P. J., Boucheix, C., Collins, F. S., Conneally, P. M., Frezal, J., Gershowitz, H., Goodfellow, P. N., Hall, J. G., Issitt, P., Jones, C. A., Knowles, B. B., Lewis, M., McKusick, V. A., Meisler, M., Morton, N. E., Rubinstein, P., Schanfield, M. S., Schmickel, R. D., Skolnick, M. H., Spence, M. A., Sutherland, G. R., Traver, M., Van Cong, N., and Willard, H. F., (1987). Guidelines for human gene nomenclature. An International System for Human Gene Nomenclature (ISGN, 1987).Cytogenet. Cell Genet. 4611–28.
Simpson, N. E., and Elliott, C. R. (1981). Cholinesterase Newfoundland: A new succinylcholine-sensitive variant of cholinesterase at locu 1.Am. J. Hum. Genet. 33366–374.
Soreq, H., Zamir, R., Zevin-Sonkin, D., and Zakut, H. (1987). Human cholinesterase genes localized by hybridization to chromosomes 3 and 16.Hum. Genet. 77325–328.
Sparkes, R. S., Field, L. L., Sparkes, M. C., Crist, M., Spence, M. A., James, K., and Garry, P. J. (1984). Genetic linkage studies of transferrin, pseudocholinesterase, and chromosome 1 loci.Hum. Hered. 3496–100.
Tunek, A., and Svensson, L. A. (1988). Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.Drug Metab. Dispos. 16759–764.
Viby-Mogensen, J. (1983). Cholinesterase and succinylcholine.Danish Med. Bull. 30129–150.
Whittaker, M. (1986).Cholinesterase. Monograph in Human Genetics, Vol. 11 Karger, Basel, pp. 1–134.
Whittaker, M., and Britten, J. J. (1985). Plasma cholinesterase variants: Family studies of the E k1 gene.Hum. Hered. 35364–368.
Whittaker, M., and Britten, J. J. (1987). E h1 , a new allele at cholinesterase locus 1.Hum. Hered. 3754–58.
Whittaker, M., and Britten, J. J. (1988). Recognition of two new phenotypes segregating the E k1 allele from plasma cholinesterase.Hum. Hered. 38233–239.
Yang, F., Lum, J. B., McGill, J. R., Moore, C. M., Naylor, S. L., Van Bragt, P. H., Baldwin, W. D., and Bowman, B. H. (1984). Human transferrin: cDNA characterization and chromosomal localization.Proc. Natl. Acad. Sci. USA 812752–2756.
Yoshida, A., and Motulsky, A. G. (1969). A Pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity.Am. J. Hum. Genet. 21486–498.
Zakut, H., Zamir, R., Sindel, L., and Soreq, H. (1989). Gene mapping on chorionic villi chromosomes by hybridization in situ: Localization of cholinesterase cDNA binding sites to chromosomes 3q21, 3a26-ter and 16q21.Hum. Reprod. 4941–946.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
La Du, B.N., Bartels, C.F., Nogueira, C.P. et al. Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing. Cell Mol Neurobiol 11, 79–89 (1991). https://doi.org/10.1007/BF00712801
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00712801